Seeking Alpha
 

WebMD Health Corp (WBMD)

- NASDAQ
  • Yesterday, 10:30 AM
    • SunTrust has upgraded WebMD (NASDAQ:WBMD) to Buy 4 days after the company beat Q2 estimates and narrowed its full-year sales guidance to $625M-$35M (+8%-9% Y/Y) from $615M-$635M.
    • WebMD's Q2 benefited from 18% and 19% Y/Y increases in monthly unique users and page views (to 212M and 4.12B, respectively), and improving demand from biopharma ad clients. Bipharma revenue is expected to be growing at an 11%-12% clip by year's end, better than the 8% growth seen during the last two years.
    | Comment!
  • Thu, May 7, 3:36 PM
    • Tech companies rallying after posting calendar Q1 reports include online textbook rental/learning services provider Chegg (CHGG +14.6%), salvage auction site Liquidity Services (LQDT +10.3%), optical component maker Emcore (EMKR +6.7%), and health site owner WebMD (WBMD +6.7%).
    • Companies declining following earnings include cloud fleet management software vendor Fleetmatics (FLTX -6.8%), seismic hardware provider Ion Geophysical (IO -11.8%), and online stock photo marketplace Shutterstock (SSTK -4.7%).
    • Chegg beat Q1 estimates on the back of an 89% Y/Y increase in digital revenue (now 39% of total revenue. Q2 revenue guidance of $61M-$65M and full-year guidance of $300M-$315M is respectively favorable to consensus estimates of $62.2M and $304.3M at the midpoints.
    • Beaten-down Liquidity beat FQ2 estimates while reporting a 16.6% Y/Y drop in GMV to $189.4M. FQ3 guidance is for GMV of $175M-$200M and EPS of $0.05-$0.10 (below an $0.11 consensus).
    • Emcore beat FQ2 estimates and is guiding for FQ3 broadband fiber division revenue of $19M-$21M, above an $18.5M consensus.
    • WebMD beat Q1 estimates on the back of 21% Y/Y increases in monthly unique users (210M) and page views (4.25B). Q2 revenue guidance of $145M-$148M is below a $151.9M consensus, but full-year revenue guidance of $615M-$635M has been reiterated.
    • Fleetmatics beat Q1 estimates, but also guided for Q2 revenue of $67.9M-$68.7M and EPS of $0.24-$0.26, below a consensus of $69.5M and $0.30. Full-year guidance is for revenue of $281M-$283M and EPS of $1.26-$1.30 vs. a consensus of $288.8M and $1.29.
    • Ion, hit hard by declining oil exploration work, missed Q1 estimates while reporting 79%, 49%, and 12% Y/Y drops in Solutions, Systems, and Software revenue. The company expects "an increase in exploration spending over the back half of the year, albeit at lower than historical levels."
    • Shutterstock beat Q1 estimates, but also forecast Q2 revenue of $104M-$106M (below a $106.1M consensus). 2015 revenue guidance of $436M-$444M is in-line with a $439.5M consensus.
    • Previously covered: Alibaba, Qorvo, SunEdison, MeetMe, Priceline, Teradata, Activision, Gogo, Atmel, Varonis, Zynga
    | Comment!
  • Wed, Apr. 8, 3:48 PM
    • Thinly-traded WebMD (WBMD +2.7%) moves up on a 3x surge volume after Goldman Sachs reverses its downgrade from Neutral to Sell back to Neutral. The firm says that it mistakenly included convertible notes when calculating diluted share count and net debt when it downgraded the company this morning.
    | 1 Comment
  • Wed, Apr. 8, 9:23 AM
    • Believing mobile monetization remains a challenge, Goldman has downgraded WebMD (NASDAQ:WBMD) to Sell, and set a $40 target.
    • Shares had risen 14% since the online health info provider posted a Q4 beat on the back of healthy traffic growth on Feb. 24. They've fallen to $45.50 premarket.
    • Update (1:20PM ET): Goldman has backtracked on the downgrade, stating its calculations were off. WebMD is now up slightly on the day.
    | Comment!
  • Thu, Mar. 26, 3:19 PM
    • Today's notable tech gainers include ultracapacitor maker Maxwell (MXWL +4.6%), SMB Web services firm Web.com (WWWW +3.7%), health site owner WebMD (WBMD +3.7%), and RF chipmaker Anadigics (ANAD +11.3%).
    • Notable decliners include NAND flash controller/4G transceiver maker Silicon Motion (SIMO -4%), hybrid storage array vendor Nimble Storage (NMBL -3.8%), local ad services provider Dex Media (DXM -8.5%). The Nasdaq is down 0.2%.
    • Maxwell's gains come a day after the company announced an ultracapacitor-based engine start module will be offered for two new Kenworth trucks. Silicon Motion has joined a slew of other chip stocks in selling off for the second day in a row. Nimble is trading near its January lows, while Dex has made fresh 52-week lows.
    • Previously covered: Cybersecurity stocks, SolarEdge, Infinera, Accenture, SuperCom, Neustar, Textura, ASML, GoPro, SanDisk, Red Hat
    | Comment!
  • Tue, Feb. 10, 9:53 AM
    • WebMD (NASDAQ:WBMD) is down 2.9% as Google (NASDAQ:GOOG) rolls out a blog post saying it will answer basic health questions with summary information, directly in search results.
    • Google says one in 20 queries are for health info, and that its users will see typical symptoms and treatments, along with illustrations, without clicking any further.
    • Google cites working with a team of doctors on the information and verifying it with the Mayo Clinic for accuracy.
    • Everyday Health (NYSE:EVDY), which has its own symptom checker, is down 1.6% as well.
    | Comment!
  • Nov. 24, 2014, 10:43 AM
    • Believing 2015 estimates are too high, SunTrust has downgraded WebMD (WBMD -2.7%) to Neutral, and slashed its target by $15 to $40.
    • Shares aren't far removed from a 52-week low of $34.48. WebMD sold off hard three weeks ago after providing soft Q4 guidance to go with mixed Q3 results.
    | Comment!
  • Nov. 5, 2014, 4:17 PM
    • Though it slightly beat Q3 revenue estimates (while slightly missing on EPS), WebMD (NASDAQ:WBMD) is guiding for Q4 revenue of $152M-$162M; the midpoint is below a $161.2M consensus.
    • The company has once more upped its buyback authorization; it now has $50M in available funds. $98.9M was spent on buybacks in Q3, and $10.2M has been spent thus far in Q4.
    • Q3 results, PR
    | Comment!
  • Nov. 5, 2014, 4:03 PM
    • WebMD Health Corp (NASDAQ:WBMD): Q3 EPS of $0.23 misses by $0.01.
    • Revenue of $143.5M (+9.6% Y/Y) beats by $0.19M.
    • Shares +1.59% AH.
    • Press Release
    | Comment!
  • Oct. 2, 2014, 11:36 AM
    • Stifel's Steven Rubis: "We are downgrading shares of WebMD (NASDAQ:WBMD) from Buy to Hold, as the preponderance of evidence associated with our channel checks reflect negative data trends and deterioration of possible positive catalysts seems to limit share price upside." His $52 target has been pulled.
    • The downgrade comes as WebMD hosts its annual meeting, and announces a partnership with Walgreens. WebMD's virtual wellness-coaching services will be offered to Walgreens customers, and WebMD's content will be integrated with Walgreens' "digital experience and stores."
    • Ahead of its annual meeting, WebMD affirmed its Q3 and full-year guidance.
    | Comment!
  • Aug. 5, 2014, 4:02 PM
    • WebMD Health (NASDAQ:WBMD): Q2 EPS of $0.23 beats by $0.04.
    • Revenue of $140.4M (+12.1% Y/Y) beats by $0.45M.
    • Shares +1.9%.
    • Press Release
    | 1 Comment
  • Jul. 2, 2014, 10:01 AM
    • Stifel's Steven Rubis has upgraded WebMD (WBMD) to Buy, and set a $60 PT.
    • Rubis: "Our upgrade stems from strong industry macro trends and our view that current estimates for 3Q14 and 4Q14 advertising revenue growth are likely conservative." He now forecasts 10% Y/Y ad growth for both Q3 and Q4, up from prior estimates of 8% and 5%. Consensus is at 10.3% and 8%.
    • Rubis adds macro trends and company-specific ad trends point to "solid" Q2 results, and thinks the Q2 report could be accompanied by a 2014 guidance hike.
    • Roughly a quarter of the float was shorted as of June 13.
    | Comment!
  • Apr. 30, 2014, 5:32 PM
    • WebMD (WBMD) expects Q2 revenue of $137M-$140M vs. a $139.7M consensus. Net income is expected to be in a range of $7.5M-$8.5M, up from Q1's $6.3M. Full-year guidance (hiked on April 14) is reiterated, and WebMD's buyback authorization has been raised by $30M to $44M. Shares +1.6% AH. (Q1 results, PR)
    • Brightcove (BCOV) expects Q2 revenue of $29.7M-$30.2M and EPS of -$0.11 to $0.12, below a consensus of $31.1M and -$0.10. Full-year guidance is healthier: Revenue of $126M-$130M and EPS of -$0.19 to -$0.25 vs. a consensus of $128.5M and -$0.35. Shares +7.2% AH. (Q1 results, PR)
    • LifeLock (LOCK) expects Q2 revenue of $113M-$114M and EPS of $0.03-$0.04 vs. a consensus of $112.6M and $0.06. Full-year guidance is for revenue of $460M-$468M and EPS of $0.44-$0.48 vs. a consensus of $463.5M and $0.45. Shares -3.8% AH. (Q1 results, PR)
    | Comment!
  • Apr. 14, 2014, 12:45 PM
    | Comment!
  • Apr. 14, 2014, 9:18 AM
    • WebMD (WBMD) expects Q1 revenue to be at the high end of a prior guidance range of $130M-$133M; the consensus is at $132.1M. Adjusted EBITDA and net income are expected to be slightly above prior guidance ranges of $28.5M-$30.5M and 3%-4% of revenue, respectively.
    • Full-year revenue, adjusted EBITDA, and net income are now expected to be at the high end of prior guidance ranges of $545M-$575M, and $140M-$155M, and $27M-$39M; the revenue consensus is at $572.6M.
    • WebMD also reports its Q1 unique users and page views respectively rose 32% and 26% Y/Y to 174M and 3.5B, and that it only has $18M remaining on its buyback authorization. The company had $51M remaining on March 21, following a $40M hike.
    • Q1 results arrive on April 30.
    | Comment!
  • Mar. 21, 2014, 12:44 PM
    • Just six weeks after adding $50M to its buyback authorization, WebMD (WBMD +5.6%) is tacking on another $40M. (8-K)
    • The company adds it has spent $58.7M in Q1 to buy back 1.4M shares (implied avg. purchase price of $41.92). After factoring those purchases, WebMD now has $51M available under its authorization.
    • WebMD spent $211.3M on buybacks in Q4. It ended 2013 with $855M in cash, and $952M in debt.
    | Comment!
Visit Seeking Alpha's
WBMD vs. ETF Alternatives
Company Description
WebMD Health Corp provides health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals and health-focused publications.